JP2005530730A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530730A5
JP2005530730A5 JP2003584041A JP2003584041A JP2005530730A5 JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5 JP 2003584041 A JP2003584041 A JP 2003584041A JP 2003584041 A JP2003584041 A JP 2003584041A JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
independently
amino
fully halogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003584041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530730A (ja
JP4578106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/011094 external-priority patent/WO2003087085A1/en
Publication of JP2005530730A publication Critical patent/JP2005530730A/ja
Publication of JP2005530730A5 publication Critical patent/JP2005530730A5/ja
Application granted granted Critical
Publication of JP4578106B2 publication Critical patent/JP4578106B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003584041A 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体 Expired - Lifetime JP4578106B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37167102P 2002-04-11 2002-04-11
PCT/US2003/011094 WO2003087085A1 (en) 2002-04-11 2003-04-10 Heterocyclic amide derivatives as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2005530730A JP2005530730A (ja) 2005-10-13
JP2005530730A5 true JP2005530730A5 (https=) 2006-06-08
JP4578106B2 JP4578106B2 (ja) 2010-11-10

Family

ID=29250721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003584041A Expired - Lifetime JP4578106B2 (ja) 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体

Country Status (9)

Country Link
US (1) US7550461B2 (https=)
EP (1) EP1497278B1 (https=)
JP (1) JP4578106B2 (https=)
AT (1) ATE469142T1 (https=)
AU (1) AU2003224923A1 (https=)
CA (1) CA2478232C (https=)
DE (1) DE60332717D1 (https=)
ES (1) ES2343787T3 (https=)
WO (1) WO2003087085A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343787T3 (es) * 2002-04-11 2010-08-10 Boehringer Ingelheim Pharmaceuticals Inc. Derivados de amidas heterociclicas de utilizacion como inhibidores de citoquina.
US7078419B2 (en) * 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
WO2005108387A2 (en) * 2004-05-03 2005-11-17 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
EP1867646A1 (en) * 2004-05-03 2007-12-19 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
JP5038139B2 (ja) * 2004-08-25 2012-10-03 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド サイトカインインヒビター
JP2008523071A (ja) * 2004-12-07 2008-07-03 ルーカス ファーマシューティカルズ, インコーポレイテッド Mapキナーゼの尿素インヒビター
EP1824843A2 (en) * 2004-12-07 2007-08-29 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
EP1838690A2 (en) * 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
EP2308839B1 (en) 2005-04-20 2017-03-01 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
CA2635888A1 (en) * 2006-01-04 2007-07-19 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
CA2722923C (en) 2008-04-29 2016-08-02 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
JP5411927B2 (ja) * 2008-05-06 2014-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr1アンタゴニストとしてのピラゾール化合物
EP2161266A1 (en) * 2008-08-22 2010-03-10 EVOTEC Neurosciences GmbH Benzofuran derivatives as orexin receptor antagonists
EP2346868B1 (en) 2008-09-26 2016-01-27 Boehringer Ingelheim International Gmbh Azaindazole compounds as ccr1 receptor antagonists
EP2491028B1 (en) 2009-10-21 2013-12-11 Boehringer Ingelheim International GmbH Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
EP2493875B1 (en) 2009-10-27 2014-08-06 Boehringer Ingelheim International GmbH Heterocyclic compounds as ccr1 receptor antagonists
WO2011137109A1 (en) 2010-04-30 2011-11-03 Boehringer Ingelheim International Gmbh Azaindazole amide compounds as ccr1 receptor antagonists
EP2655371B1 (en) 2010-12-23 2015-02-25 Boehringer Ingelheim International GmbH Pyrazolopiperidine compounds as ccr1 receptor antagonists
CN117510460B (zh) * 2023-10-30 2026-02-06 贵州大学 一种含磺酰胺单元的苯并[b]噻吩衍生物、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317076A1 (de) * 1993-05-21 1994-11-24 Bayer Ag Benzthiophencarbonsäureamid-S-oxide
DE19642529A1 (de) * 1996-10-15 1998-04-16 Bayer Ag Aminophenolderivate
US5994398A (en) * 1996-12-11 1999-11-30 Elan Pharmaceuticals, Inc. Arylsulfonamides as phospholipase A2 inhibitors
CA2328927C (en) * 1998-05-15 2008-02-19 Astrazeneca Ab Benzamide derivatives for the treatment of diseases mediated by cytokines
EP1115707B1 (en) * 1998-09-25 2003-11-12 AstraZeneca AB Benzamide derivatives and ther use as cytokine inhibitors
NZ528846A (en) * 1999-03-12 2005-05-27 Boehringer Ingelheim Pharma Compounds useful as anti-inflammatory agents
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
WO2002012189A1 (en) * 2000-08-09 2002-02-14 Mitsubishi Pharma Corporation Fused bicyclic amide compounds and medicinal use thereof
MXPA03009000A (es) 2001-04-13 2004-02-12 Boehringer Ingelheim Pharma Compuestos benzo-fusionados 1,4-disustituidos.
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
ES2343787T3 (es) * 2002-04-11 2010-08-10 Boehringer Ingelheim Pharmaceuticals Inc. Derivados de amidas heterociclicas de utilizacion como inhibidores de citoquina.

Similar Documents

Publication Publication Date Title
JP2005530730A5 (https=)
CN1095841C (zh) 化合物
JP2000515136A (ja) プロテインチロシンキナーゼ阻害剤としての二環式ヘテロ芳香族化合物
JP5735986B2 (ja) 新規抗マラリア剤
JP2005519932A5 (https=)
JP2007536231A5 (https=)
JP4196678B2 (ja) 複素環化合物
EA002113B1 (ru) Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
SK133297A3 (en) Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use
CA2478232A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
JP2005508960A5 (https=)
JP2002538157A (ja) ピラゾロピリジン
JP2005511532A5 (https=)
JP2007537255A5 (https=)
JPH08504435A (ja) タキキニン受容体拮抗剤としての4−アミノメチル/チオメチル/スルホニルメチル−4−フェニルピペリジン
JP2005509003A5 (https=)
NO312959B1 (no) Substituerte indazolderivater, anvendelse derav samt farmasöytisk preparat
CA1144550A (en) Antiinflammatory 4,5-diaryl-2-(substituted-thio) pyrroles and their corresponding sulfoxides and sulfones
JPS62452A (ja) 1,8−架橋−4−キノロン−3−カルボン酸類の製造法、それらの中間体類、および薬物としてのそれらの使用
JP2006514940A5 (https=)
JPWO2009041447A1 (ja) 5員複素環化合物
EP1109809A1 (en) Pyrroloquinolines for treatment of obesity
HRP20030141A2 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
JP2014513142A (ja) ナフチリジンの調製方法
CA2507184A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors